Background: Actin cytoskeletal networks push and pull the plasma membrane (PM) to control cell structure and behavior. Endocytosis also regulates the PM and can be promoted or inhibited by cytoskeletal networks. However, endocytic regulation of the general membrane cytoskeleton is undocumented. Results: Here, we provide evidence for endocytic inhibition of actomyosin networks. Specifically, we find that Steppke, a cytohesin Arf-guanine nucleotide exchange factor (GEF), controls initial PM furrow ingression during the syncytial nuclear divisions and cellularization of the Drosophila embryo. Acting at the tips of ingressing furrows, Steppke promotes local endocytic events through its Arf-GEF activity and in cooperation with the AP-2 clathrin adaptor complex. These Steppke activities appear to reduce local Rho1 protein levels and ultimately restrain actomyosin networks. Without Steppke, Rho1 pathways linked to actin polymerization and myosin activation abnormally expand the membrane cytoskeleton into taut sheets emanating perpendicularly from the furrow tips. These expansions lead to premature cellularization and abnormal expulsions of nuclei from the forming blastoderm. Finally, consistent with earlier reports, we also find that actomyosin activity can act reciprocally to inhibit the endocytosis at furrow tips. Conclusions: We propose that Steppke-dependent endocytosis keeps the cytoskeleton in check as early PM furrows form. Specifically, a cytohesin Arf-GEF-Arf G protein-AP-2 endocytic axis appears to antagonize Rho1 cytoskeletal pathways to restrain the membrane cytoskeleton. However, as furrows lengthen during cellularization, the cytoskeleton gains strength, blocks the endocytic inhibition, and finally closes off the base of each cell to form the blastoderm.
Introduction
Coupling actomyosin networks to the plasma membrane (PM) is essential for cells to migrate, interact, change shape, and divide [1] [2] [3] [4] [5] . As examples, actin networks form and function at the leading edge of migratory cells, at cell-substrate adhesion complexes, and at cell-cell adhesion complexes in multicellular tissues. To assemble these complexes, receptors can physically engage the actin cytoskeleton and also induce cytoskeletal assembly via Rho-family guanosine triphosphate (GTP)ases and phosphoinositide signaling [6, 7] . Inversely, endocytosis can remove receptors from the PM promoting the turnover of adhesion and signaling complexes [4, 8, 9] . More generally, the close links of both actin networks and endocytic machinery with the PM suggest possible crosstalk between these subsystems. Indeed, endocytic signaling nucleates local actin networks to help drive membrane invagination and scission [10, 11] . In contrast, more widespread membrane cytoskeleton activity can create tension that inhibits membrane invagination [12, 13] . Conceivably, endocytosis could also inhibit the membrane cytoskeleton, but such activity is undocumented.
The syncytial Drosophila embryo is a well-established model for studying actomyosin networks and membrane trafficking during PM furrow ingression. In the early syncytial embryo, nuclei divide synchronously just beneath the PM. At each division cycle, the activities of Rho-family GTPases [14] [15] [16] , the Arp2/3 complex [17, 18] , and the formin Diaphanous (Dia) [19] organize actomyosin-based PM ingressions (pseudocleavage furrows) that surround each nucleus to prevent nuclear collision and loss. Once w6,000 nuclei form, similar mechanisms induce a final round of PM ingressions. These furrows persist and elongate through membrane trafficking to apical and lateral sites [20] [21] [22] , and with support of actomyosin networks at their basal tips (the furrow canals) [21, 23] . This massive PM growth cellularizes the first embryonic epithelium, a process completed with constriction of actomyosin rings formed at the base of each cell [21, 23] .
Recently, endocytic events were detected at the tips of pseudocleavage furrows and early cellularization furrow canals by the presence of Amphiphysin (Amph)-positive tubules and the internalization of labeled PM [24] . These events have provided a model for studying how the actin cytoskeleton can both promote and inhibit endocytosis [24, 25] . However, the role of this endocytosis is unclear, and paradoxically, it would appear to counteract membrane growth. We examined how Arf G protein (Arf) activation might be involved. In other contexts, Arfs promote endocytosis by recruiting coat proteins, activating lipid signaling, and triggering actin polymerization [26] [27] [28] [29] . Like other G proteins, Arfs are activated by guanine nucleotide exchange factors (GEFs). Cytohesins are a major class of PM Arf-GEFs [27] , and roles for cytohesin Arf-GEFs have been documented at migratory leading edges, focal adhesions, and adherens junctions in mammalian cell culture [30] [31] [32] . Drosophila contains one cytohesin, called Steppke (Step) [26] .
Step is known to function in postembryonic insulin and EGF signaling [33, 34] , which mammalian cytohesins do as well [27, 35] , but its contributions to the Drosophila embryo and to other cellular processes are unknown. Here, we show that Step promotes endocytosis at pseudocleavage furrows and furrow canals to restrain actomyosin networks at these sites.
Results
Step Promotes Endocytic Tubules and Restrains the Cytoskeleton at PM Furrows To test how Step affects endocytosis at cellularization furrow canals, we began by perturbing maternal supplies of Step and used Amph as a probe for endocytosis. In wild-type (WT), Amph-positive tubules emanate from early furrow canals ( Figure 1A , arrows) and tubule numbers decrease as furrows lengthen ( Figure 1A ) [24] . We performed loss-of-function experiments with maternally supplied step short hairpin RNA *Correspondence: tony.harris@utoronto.ca (shRNA) or with females transheterozygous for two hypomorphic alleles with a 93% reduction of maternal step mRNA [33] and analyzed progeny at early cellularization. The tubules were largely abolished in both cases ( Figure 1A) .
Since endocytosis and the PM are intimately linked, we probed PM organization. step loss-of-function embryos displayed abnormal expansions of furrow canal PM (seen with Amph staining [ Figure 1B ] and the PM markers Discs large [Dlg] [see also Figure S1A available online] and DE-cadherin [data not shown]). The membranes expanded as taut, thin sheets perpendicular to the ingressing furrows and invaded space normally occupied by nuclei, which clustered abnormally, constricted in the plane of the expanded membrane, or were lost ( Figures 1B-1E ). Across populations of embryos, the tubule loss appeared more penetrant than the PM expansion ( Figure S2A ). Most embryos failed to recover from these defects, and substantial lethality occurred ( Figure S2B ).
The PM expansion with step loss of function ( Figure 1B ) was consistent with a decrease to endocytosis but also partially mimicked the bottleneck mutant phenotype, in which premature actomyosin constriction expels nuclei from the presumptive epithelium [36] . To test if
Step also counteracts actomyosin networks, we probed actin in step loss-of-function embryos. In early WT embryos, furrow canal F-actin is organized as a ring that emanates short bundled filaments connecting to F-actin on the upper portion of the furrows ( Figure 1C ). At early cellularization in step loss-of-function embryos, F-actin appeared normal over the upper furrow membrane but spread perpendicularly into taut, thin networks at the furrow canals ( Figure 1C ), as seen for the PM. The total intensity of F-actin staining was elevated at the level of the furrow canals in step loss-of-function embryos versus WT ( Figure S3 ), and the expanded membranes were also coated with the septin Peanut and Anillin ( Figure S1B ). Nuclei were displaced above and below the expanded actin networks, with some pinched into bottle-like shapes ( Figure 1D ). Thus, without Step, the furrow canal membrane cytoskeleton abnormally expands while remaining a taut sheet that displaces nuclei from the forming epithelium ( Figure 1E ).
The reduced number of nuclei and the variability of the membrane expansions in cellularizing step loss-of-function embryos contrasts the bottleneck cellularization phenotype [36] and suggested defects during earlier syncytial nuclear divisions (specifically during cycles 10-13, when the nuclei localize to the embryo periphery and engage the PM). Indeed, live imaging of Zipper-GFP (Zip-GFP; nonmuscle myosin II heavy chain) revealed abnormal expansion of actomyosin networks at ingressing furrows starting typically at the second peripheral nuclear division (cycle 11) (Figure 2A ). This expansion appeared to precede major nuclear loss and then increased progressively through the remaining division cycles and into cellularization (Movies S1, S2, and S3). As in WT, Zip-GFP networks disassembled at each metaphase in step loss-of-function embryos (Movies S1, S2, and S3; Figure 2B , although incomplete disassembly was observed in severely disrupted embryos [red asterisks]), suggesting myosin II inhibition by Cdc2 [37] is independent of Step. With Step loss, the early expanded networks had significantly greater total Zip-GFP fluorescence than WT (Figure 2A) , a difference that was maintained into cellularization ( Figure S3 ). Side views showed that the networks expanded only in the plane of the furrow tips ( Figure 2B ) and that furrow ingression was often disrupted ( Figure 2B , red arrows). Zip-GFP displayed local intensity fluctuations within the abnormally expanded networks (Movie S3), suggestive of local myosin II contractions within broad actomyosin networks. The progressive actomyosin network buildup coincides specifically with when endocytosis normally occurs at ingressing furrows during syncytial nuclear divisions and cellularization [24] , and we found that Amph tubule numbers were also decreased at pseudocleavage furrows of step loss-of-function embryos ( Figure 2C) . Thus, the timing of the step phenotype is distinct from that of bottleneck, which specifically functions at cellularization [36] . Instead, Step appears to promote endocytosis and inhibit actomyosin networks at all early PM ingressions of the syncytial embryo.
Step Antagonizes Rho1 Pathway Activity at PM Furrows To test if the step loss-of-function phenotype is due to actomyosin overactivity, we attempted to suppress it by weakening actomyosin networks. The Rho1 pathway promotes actin polymerization through formins and activates myosin II [38] , and, as discussed, these pathways promote pseudocleavage and cellularization furrow stability. Thus, we tested whether a reduction in Rho1 activity could suppress the step loss-offunction phenotypes. Maternal heterozygosity for rho1 72O suppressed the step RNAi furrow canal expansion and nuclear loss phenotypes to nearly WT ( Figure 3A ; Figures S4A and S4B; also seen for rho1 72F [data not shown]). To assess the Rho1 pathway involved, we examined step RNAi embryos derived from mothers heterozygous for either dia 5 (the Drosophila formin regulated by Rho1) or zip 1 alone but observed no suppression (data not shown). However, heterozygosity for both dia 5 and zip 1 suppressed the step RNAi furrow canal expansion and nuclear loss phenotypes substantially, albeit more weakly than the heterozygosity for rho1 72O ( Figure 3A ; Figures S4A and S4B ). The suppression of the abnormal furrow canal expansion in these experiments argues that
Step normally antagonizes Rho1-induced actin polymerization and myosin II activation at PM furrows. The suppression of the abnormal nuclear loss further indicates that this antagonism occurs at furrows throughout the nuclear division stages and into cellularization.
To investigate how
Step antagonizes the Rho1 pathway, we began by probing Rho1 protein localization in step RNAi and WT embryos at early cellularization. Both showed weak Rho1 staining over furrow canal membranes ( Figure 3B ), but the total intensity was greater for step RNAi embryos ( Figure S3 ). One concern was that more Rho1 was detected at the furrow canals of step RNAi embryos as a nonspecific consequence of the expanded furrow canal membranes in these embryos. To separate the analysis of Rho1 levels from the effects of elevated actomyosin activity on membrane architecture, we analyzed step RNAi embryos derived from mothers heterozygous for both dia 5 and zip
1
, in which the furrow expansion phenotype was suppressed. Strikingly, for similarly sized membranes, furrow canal Rho1 levels were higher in the suppressed step RNAi embryos versus WT ( Figure 3C ; maternal heterozygosity for both dia 5 and zip 1 without step RNAi had no effect on Rho1 levels, Figure 3D ). Since RhoGEF2 is the main upstream recruiter of Rho1 to furrow canals [14, 16] , we tested its localization but observed no change between the genotypes, in contrast to counterstained Rho1 ( Figure 3E ). To address the possibility that the higher Rho1 levels could be linked to a residual elevation of F-actin in the suppressed step RNAi embryos, we quantified furrow canal phalloidin staining levels, but they were indistinguishable between similarly sized membranes of each genotype ( Figure 3F ). Thus, Step appears to inhibit furrow canal Rho1 protein levels through a mechanism independent of both local RhoGEF2 levels and effects on actomyosin networks.
Since weakening the Rho1 pathway suppressed the step loss-of-function phenotype, we predicted that directly stabilizing actin would mimic the phenotype. Thus, we treated permeabilized Zip-GFP embryos with the F-actin stabilizer jasplakinolide and analyzed early cellularization. In contrast to carrier control, the treatment led to binding of jasplakinolide to F-actin ( Figure S5B ), increased Zip-GFP levels ( Figures S5A  and S5C ), furrow canal PM expansion ( Figures S5A, S5B , and S5D), and nuclear loss ( Figure S5B ). The similarity of these effects to the defects observed with step loss-of-function further argues that the step loss-of-function phenotype is due to excess actomyosin. Note, however, that the furrow expansion is milder and more even across the embryo with the jasplakinolide treatment than with the loss of Step. In part, this difference can be attributed to the timing of the (A) Timeframes of 3D projections show mild and severe expansions of Zip-GFP networks in step mutants versus WT from the second or third peripheral nuclear division (cycles 11 and 12) through cellularization (Movies S1 and S2). Data were collected and adjusted with the same settings. Below, Zip-GFP levels quantified at cycle 12 prophase (p = 0.027 for t test of mean intensities of each embryo). (B) Side views of the embryos shown in (A) through cycles 11-13 reveal that the expanded Zip-GFP networks are at the tips of pseudocleavage furrows (white arrows in control). Note, however, defects in furrow ingression occurred in step mutants (red arrows). Also, in WT, PM myosin II is normally lost at metaphase of each cycle [37] , but in severely affected step mutants, some Zip-GFP persisted (asterisk). Similar overall results were seen with Zip-GFP in step RNAi embryos (data not shown). (C) Loss of Amph-positive tubules, expansion of Amph-positive PM at furrow tips, and loss of nuclei in step mutants versus control at cycle 13. Data are quantified at right with means 6 SD for step mutants and RNAi.
perturbations, with the jasplakinolide treatment affecting a 30 min period during cellularization and the Step loss affecting all syncytial stages.
Of note, Amph-positive tubules were also lost with the jasplakinolide treatment and, to a lesser extent, with the carrier control ( Figures S5A and S5E ). This result suggests that Figure S3 . (C) Suppressed step RNAi embryos from mothers heterozygous for both dia 5 and zip 1 . Local Rho1 levels are higher than WT furrow canal membranes of similar size from internal controls. (D) Maternal heterozygosity for both dia 5 and zip 1 alone has no effect on Rho1 furrow canals levels versus internal control. (E) Suppressed step RNAi embryos from mothers heterozygous for both dia 5 and zip 1 with internal control. Costaining Rho1 and RhoGEF2 shows the abnormal increase of Rho1 levels occurs without a corresponding increase in RhoGEF2 levels. (F) Suppressed step RNAi embryos from mothers heterozygous for both dia 5 and zip 1 with internal control. No difference in F-actin levels was detected. (C-F) Quantifications were normalized to the average internal WT control level in each costaining experiment.
actomyosin networks can inhibit endocytic activity at furrow canals. Similarly, Amph-positive tubule numbers and morphology were restored in step RNAi embryos with maternal heterozygosity for rho1 72O ( Figure 3A ; Figure S4C ), suggesting that some endocytosis can occur with step loss of function but is inhibited by abnormal actomyosin elevation. These data and other reports of actin inhibiting endocytosis at furrow canals in this system [24, 25] made it important to distinguish two main models for how Step could function: (1) as a promoter of endocytosis that in turn inhibits the membrane cytoskeleton, or (2) as an inhibitor of the membrane cytoskeleton that otherwise inhibits endocytosis.
Step Localizes to Furrows and Restrains the Cytoskeleton via Its Arf-GEF Activity To further probe how Step functions and to begin to distinguish if its primary effects are on endocytosis or on the actomyosin cytoskeleton, we constructed and overexpressed GFP-Step and GFP-Step E173K with an inactivating mutation in its Arf-GEF domain [39, 40] . Both proteins localized along early cellularization furrows with furrow canal enrichment ( Figure 4A ), overlapping partially with Amph at furrow canals, but with no detection at the tubules. Intriguingly, 55% (72/ 131) of GFP-Step embryos had furrows of varying lengths ( Figure 4A ), suggesting local defects in furrow formation or stability, and ultimately most die as embryos ( Figure S2B ). We noted that more severe phenotypes correlated with greater GFP-Step levels at the furrows (data not shown). In contrast, GFP-Step E173K embryos extended furrows normally and synchronously ( Figure 4A ; 2/84 had shortened furrows), despite equal or greater GFP-Step E173K levels at furrows, and had background embryonic lethality ( Figure S2B) .
The furrow loss with
Step overexpression resembled that of mutants with weakened actin networks such as nullo [ Step is enriched at early furrow canals and destabilizes furrows (brackets). GFP-Step E173K (Arf-GEF inactive) is enriched at early furrow canals but has no effect on furrows. 0 mm set just below furrow canals for reference, and z sections are shown at 0.6 mm intervals above this point. (B) Loss of phalloidin-stained F-actin from furrow canals with GFP-Step overexpression (arrows) versus WT and GFP-Step E173K overexpression. (C) RNAi-resistant GFP-Step can rescue step RNAi-induced Amph-positive tubule loss, furrow canal PM expansion, and nuclear loss, but RNAi resistant GFP-Step E173K cannot.
probed F-actin at early furrow canals. In WT embryos, F-actin was strongly enriched at each furrow canal, whereas furrow canal F-actin levels were variable in 12/24 GFP-Step embryos, suggestive of local destabilizations, but not in 7/7 GFP-Step E173K embryos ( Figure 4B ). These results suggest that Step impacts actomyosin networks through its Arf-GEF activity. To further validate the constructs and test the role of Step Arf-GEF activity, we made RNAi-resistant forms of GFP-Step and GFP-Step E173K and coexpressed them maternally with step shRNA. Expression of RNAi-resistant GFP-Step substantially rescued the step RNAi furrow canal expansion and nuclear loss phenotypes ( Figure 4C ; 21/25 embryos resembled WT; 3/25 had the Step overexpression phenotype; and 1/25 had the step RNAi phenotypes). We noted that the rescue occurred over a range of GFP-Step levels at the furrows (data not shown). In contrast, RNAi-resistant GFP-Step E173K failed to rescue the step RNAi phenotypes ( Figure 4C ; 6/45 embryos resembled WT and 39/45 had step RNAi phenotypes) despite equal or greater levels at furrows. These PM comparisons indicate that Step Arf-GEF activity is critical for regulating PM furrows, and the nuclear loss comparisons argue that this regulation occurs throughout the nuclear division stages and into cellularization.
Step Acts with AP-2a to Restrain the Membrane Cytoskeleton One way that Arfs promote endocytosis is through the recruitment of coat proteins. In mammalian cells, Arfs can recruit clathrin and its adaptor complex AP-2 [44] [45] [46] . Thus, we pursued the AP-2 a subunit (AP-2a), beginning with maternal shRNA experiments. AP-2a shRNA led to two main classes of PM furrow defects, in contrast to the WT appearance of control shRNA embryos. The first main class included various degrees of furrow loss ( Figures 5A and 5B ) consistent with known roles of endocytosis and membrane recycling in fuelling furrow growth [22] . Strikingly, the second main class involved abnormal PM expansions, specifically at furrow tips at both cellularization and earlier syncytial divisions ( Figures  5A and 5B ). This second class of embryos also lacked Amph-positive tubules ( Figure 5A ; 18/22 cellularization and precellularization embryos with furrow lengths below 4 mm showed a marked reduction in tubules versus controls).
Expression of AP-2a shRNA in mothers heterozygous for the AP-2s KG02457 allele increased the proportion of embryos in each of the classes ( Figure 5B ; control shRNA in mothers heterozygous for the AP-2s KG02457 had no effect on the classes), suggesting roles for the overall AP-2 complex in both fuelling and restraining furrow growth. Moreover, expression of AP2a shRNA in mothers heterozygous for the strong step K08110 allele [33] increased the proportions of embryos in each class, and expression in mothers heterozygous for the weak step SH0323 allele [33] increased the proportion of embryos with furrow loss ( Figure 5B ; control shRNA in mothers maternally heterozygous for these alleles produced neither class). The similarity of the PM expansions in both step and AP-2a loss-of-function embryos and the enhanced phenotype with double disruption argue that Step acts with AP-2a to restrain the membrane cytoskeleton at furrow tips. Also, Step appears to contribute to AP-2 function in furrow growth, although step loss-of-function embryos did not display furrow loss on their own.
To test if
Step is required for recruiting AP-2 to furrow canals, we first stained for AP-2a in WT and step RNAi embryos at early cellularization. Lateral AP-2a levels were similar in each case, but furrow canal levels were difficult to compare because of the abnormally expanded PM with step RNAi ( Figure 5C ). To compare furrows with similar overall structure, we examined step RNAi embryos from mothers heterozygous for rho1 72O . At early cellularization, both these suppressed embryos and controls displayed indistinguishable lateral localization and furrow canal enrichment of AP-2a ( Figure 5C ). Thus, AP-2a recruitment to furrows and furrow canals appears to be independent of Step. Moreover, we performed peri-vitelline injections of fluorescently tagged wheat germ agglutinin (WGA) to label the outer surface of the apical PM and observed live endocytic events from invaginating furrows in both WT and step RNAi embryos ( Figure S6) . Thus, the loss of Step does not eliminate general endocytosis at the PM furrows. Rather, the cooperation of Step and AP-2a in restraining the membrane cytoskeleton appears to represent one aspect of overall AP-2 activity.
Step Can Induce Ectopic Endocytic Activity at Furrow Tips without Apparent Effects on Actin Since the canonical role for PM Arfs and AP-2 is the induction of endocytosis, we hypothesized that
Step primarily promotes endocytosis that in turn inhibits actomyosin networks. As an additional test of this model, we asked if GFP-Step could induce ectopic endocytosis at furrow canals and, if so, whether this effect would coincide with a decrease in furrow canal Factin or not. At later cellularization, Amph-positive tubules are normally lost from furrow canals [24] ( Figure 6B ). Overexpressed GFP-Step and GFP-Step E173K became strongly enriched at these later furrow canals ( Figure 6A ). Focusing on embryos that passed earlier cellularization without apparent defects, we found that GFP-Step induced ectopic tubules at later furrow canals, whereas GFP-Step E173K had a slight dominant-negative effect ( Figure 6B ). Counterstaining for Dlg confirmed that the induced Amph-positive tubules extended below the base of the PM furrows (Figure 6C , arrows; also confirmed with Neurotactin as a PM marker [data not shown]). We also stained for AP-2a in this class of embryos and found elevated staining at furrow canals of GFP-Step-overexpressing embryos, but not GFP-Step E173K -overexpressing embryos, versus WT ( Figure 6D ). To test if the elevated endocytic activity arose because of F-actin disruption by GFP-Step, we probed actin in GFP-Step and WT embryos at mid-late cellularization but found no effects on furrow canal phalloidin staining level or pattern regardless of GFP-Step expression level ( Figure 6E) . Similarly, we observed no effects on the septin Peanut (data not shown). These results contrast effects seen in nullo and dia mutants, in which abnormally high tubule numbers are found at later cellularization but coincide with abnormally low furrow canal F-actin levels [16, 24, 25, 41] . Our data indicate that Step Arf-GEF activity can induce endocytic activity at furrow canals without apparent actin inhibition.
Discussion
Our data provide the first description of cytohesin function in a developing embryo. We find that Drosophila Step promotes a subset of endocytic events at the tips of ingressing PM furrows during embryo cellularization. Endocytosis has been documented previously at these sites [24] , but its role has been unclear. By manipulating a conserved upstream activator of endocytosis, we identify an important role of endocytosis in controlling the membrane cytoskeleton. Our data argue that Step acts at furrow tips to induce local Arf-dependent endocytosis, which in turn antagonizes Rho1-dependent actomyosin network assembly at these sites ( Figure 6F ).
We also find that the cytoskeleton can inhibit endocytosis at the furrow tips, as has been previously shown in this system [24, 25] and in other contexts [12, 13] . We propose an overall model in which this reciprocal relationship is one-sided at specific developmental stages. At newly forming PM furrows, Step dominates, promoting endocytosis that keeps cytoskeleton activity in check for proper pseudocleavage and cellularization furrow architecture and growth. During later cellularization, the cytoskeleton dominates. Zygotic expression of actin regulators such as Nullo normally increases actomyosin activity as cellularization proceeds [41] and appears to work in conjunction with Dia to block endocytic events at the furrow tips [24, 25] . By counteracting the inhibitory endocytosis, cytoskeletal activity would elevate further but at these later stages is locally restrained by a distinct mechanism requiring Bottleneck [36] . To form the blastoderm, this second restraint mechanism is removed, and contractile rings close off the base of each cell. In the absence of the initial Step-mediated restraint mechanism, we propose that the cytoskeleton abnormally dominates the relationship at all early PM furrows. Without
Step-based endocytic inhibition, we speculate that actomyosin networks abnormally expand and inhibit other endocytic events leading to coexpansion of cytoskeletal polymers and PM from the furrow tips.
An important element of the model is the local induction of endocytic events. Our data localize
Step to the tips of ingressing PM furrows, and both the loss and overexpression of Step alter membrane organization specifically at these sites. This localized Step-regulated activity occurs in a dynamic global membrane trafficking system within each forming cell. During the peripheral nuclear divisions, each nucleus acquires its own endoplasmic reticulum and Golgi apparatus that function with recycling endosomes to direct exocytosis to growing PM furrows at cellularization [22, 47, 48] . Simultaneously, endocytic events occur over the apical PM and at the furrow tips [22, 24, 25] , with endocytosed material recycled to the growing furrows [22] . Thus, the overall membrane system is in continual flux, and coordination by local regulation would be expected. Our data identify a polarized endocytic activator required for the process.
Step Arf-GEF activity is critical for restraining the membrane cytoskeleton at furrow tips, and a subset of AP-2 activities is involved as well.
How could endocytosis and actomyosin networks impact each other at the tips of PM furrows or elsewhere? This question can be considered from several levels of organization. First, a simple and direct connection could be endocytic removal of one or more PM actomyosin regulators. Our work identifies Rho1 or an upstream regulator as a candidate. Intriguingly, membrane trafficking has been previously linked to the Rho1 pathway in this context. Specifically, recycling endosomes have been implicated in the trafficking of RhoGEF2 to the PM [15] . We hypothesized that RhoGEF2 might also be a target of Step for its removal from the PM but found no difference in RhoGEF2 levels at furrow canals in step loss-of-function embryos. Thus, Rho1 may be a more specific target of Step, although a direct connection to the Rho1 pathway remains to be determined. Of note, a number of septins have also recently been observed on the Amphpositive tubules [49] .
Second, interplay between different pools of actin is possible. For example, actin contributes to the invagination and scission of endocytic vesicles [11, 24] , and thus, endocytic actin and other PM actin networks could compete for regulators or components. Additionally, there could be signaling crosstalk between regulators of the different networks. For example, Arf signaling often elicits local Rac or Cdc42 activity [29, 50] , and this might trigger crosstalk affecting Rho activity [51] . Interestingly, overexpression of Cdc42-interacting protein 4 (Cip4) appears to antagonize Dia at furrow canals, although Cip4 mutants have no cellularization phenotype on . This is apparent in side views comparing top of furrows to furrow canals (yellow arrow). The change was also apparent in single xy sections at furrow canals (quantified at right over populations of embryos; results reproducible over two to three staining experiments). (E) Furrow canal phalloidin staining was indistinguishable between GFP-Step overexpressing and internal WT controls regardless of GFP-Step levels (GFP-Step and phalloidin measured at the same furrow canal sites; quantified from two experiments).
(F) A model of Steppke-regulated endocytic antagonism of the membrane cytoskeleton during early PM furrow formation (shown for cellularization). their own [25] . Significantly, however, we find that Step acts with AP-2 to control the membrane cytoskeleton. This
Step-AP-2 cooperation suggests that clathrin-coated pits are involved in the antagonism, although it does not exclude the possibility of separate cytoskeletal crosstalk.
Third, larger scale interactions should be considered. Endocytosis could remove membrane in bulk that would otherwise support the membrane cytoskeleton, although our observations of residual furrow canal endocytic activity with step loss of function suggest a more specific mechanism. Inversely, the membrane cytoskeleton could block endocytosis by elevating PM tension [12, 13] or possibly by sterically blocking endocytic machinery from accessing the PM.
Endocytic-cytoskeletal crosstalk is relevant to many cellular processes. For example, receptor endocytosis occurs in proximity to actomyosin networks in various contexts, including migratory leading edges, focal adhesions, and adherens junctions [4, [7] [8] [9] . However, these endocytic events and actomyosin networks have mainly been studied independently, and thus their functional integration is not understood. Our work highlights the possibility that endocytic activity at such assemblies could simultaneously remove receptors and antagonize local cytoskeletal networks, with both effects promoting complex turnover and cellular dynamics.
Experimental Procedures
RNAi, mutant, and overexpression studies were conducted using standard Drosophila genetic approaches. Other embryo manipulations also followed standard methods. Embryo imaging was done with z stacks with 300 nm step sizes with a spinning-disk confocal system (Quorum Technologies) at room temperature with a 633 Plan Apochromat NA 1.4 objective (Zeiss), a piezo top plate, an electron-multiplying charge-coupled device (EM CCD) camera (Hamamatsu Photonics), and Volocity software (PerkinElmer). All Drosophila stocks, reagents, postacquisition image analyses, quantifications, and detailed methods are described in the Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes six figures, Supplemental Experimental Procedures, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.cub.2013.08.058.
